Need Custom Pricing? Request a Quote!
Request a free quote for bulk orders or repairs—response in 24 hours. Or get tailored advice and a quote for your automation needs.
Get Your Free Quote!
PLCs offer pharmaceutical companies a reliable, efficient way to meet FDA 21 CFR Part 11 compliance. Through the automation of data recording, record-keeping, and approvals, PLCs minimize risk, enhance quality, and make compliance easier to manage.
In pharmaceutical manufacturing, there is no margin for mistakes. Product quality directly affects the health of patients, so regulatory scrutiny is severe and unavoidable. For many years, firms used piles of paperwork to record each stage in the manufacturing process. It was a slow, inefficient, error-prone process. Nowadays, the sector has moved to digital systems, but that comes with its own set of problems. The US Food and Drug Administration (FDA) created the 21 CFR Part 11 regulation to govern these electronic records and signatures to ensure that they are secure and trustworthy.

To see how these two topics connect, it is important to first have a clear picture of what each one is. A PLC is the hardware that runs the factory floor, while 21 CFR Part 11 is the set of rules that governs the data it produces.

A Programmable Logic Controller, or PLC, is an industrial-grade computer rugged enough to be the brain of an automated manufacturing process. It accepts input from devices such as sensors and switches, processes the data according to a pre-stored program, and then transmits instructions to output devices such as motors, valves, and heaters. In a pharmaceutical facility, PLCs are everywhere. They accurately control:
The PLC is the source of truth for what's happening on the line. Every temperature reading, every valve opening, and every motor start is initiated or sensed by a PLC, so it's the primary generator of critical process data.

The FDA 21 CFR Part 11 rule establishes the criteria under which the FDA will accept electronic records and electronic signatures equivalent to paper records and hand-written signatures. For a pharmaceutical company to use a digital system for any Good Manufacturing Practice (GMP) activity, that system must comply with this rule. The regulation is built on a few core pillars:
These requirements help prevent mistakes, fraud, and data loss, protecting both patients and businesses.

A contemporary PLC, when combined with an HMI or SCADA system, possesses the technical ability to satisfy each of Part 11's requirements. Here's an explanation of how this connection works in practice.

Trustworthy data starts with trustworthy collection. PLC systems build this trust by taking human error out of the equation. Instead of an operator reading a gauge and writing down a number, the PLC captures data directly from electronic sensors that measure process variables like temperature, pressure, and weight.
This digital data is automatically sent to a central database, creating a reliable electronic record of exactly what happened during a batch. This process eliminates typos, rounding mistakes, and the chance of someone writing down an incorrect value.

Part 11 requires a permanent record of all actions. Modern PLC/SCADA systems do this automatically, acting as a constant observer that logs every important event. This secure, computer-generated audit trail captures the "who, what, when, and why" for all critical actions.
For instance, if a supervisor changes a temperature setpoint from 37.0°C to 37.5°C, the system records:
This log is stored securely and cannot be edited by operators, providing an objective record for reviews and inspections.

To ensure accountability, PLC systems control who can use the equipment and what they are allowed to do. This is managed through user roles with specific permissions. For example:
This tiered structure ensures people only have access to the functions they need for their job, reducing the risk of unauthorized changes.

Electronic signatures are like digital sign-offs for important steps. A PLC can be programmed to pause the process and require a signature before continuing. For example, after an operator adds a raw material to a tank, the HMI screen will prompt for verification. To proceed, the operator must provide their electronic signature, usually by re-entering their unique username and password. This creates a permanent, signed record confirming that a specific person took responsibility for that critical step.

It is only half the fight to have the correct technology. Pharmaceutical firms need to follow a structured approach that integrates technology, validation, and procedures in order to successfully implement a compliance automation system.

The simplest way to be compliant is to begin with a system that is designed for it. When choosing new PLCs, HMIs, and SCADA software, find platforms that offer built-in features for Part 11. These often include user management modules, audit trails, and electronic signatures that can be easily configured straight out of the box. Building compliance into the system from the very start is much more efficient and cost-saving than attempting to add it to a system that was not designed for it.

Under FDA guidelines, having a compliant system is not sufficient; you have to demonstrate that it is functioning as required in your particular environment. This is done by a rigorous validation process:
Validation creates the documented evidence that your PLC automation system is correct, reliable, and fit for purpose.

Technology cannot operate in a vacuum. It has to be backed up by good, well-implemented Standard Operating Procedures (SOPs). Procedural controls manage the human interaction with the system. The key SOPs for a Part 11 compliant system are:
A: This can be challenging and expensive. Older PLCs typically do not have the necessary features for secure audit trails or user management. A workaround is to put a newer HMI or SCADA on top of the legacy PLC. The HMI manages the Part 11 features, such as access control and logging, and the PLC still operates the machine. However, for long-term performance and reliability, a complete system upgrade is typically the preferred option.
A: No. The PLC is an important component, but it does not achieve compliance on its own. Compliance is for the system as a whole, including the PLC, the HMI/SCADA computer program, the computer network, the server database in which the data is kept, and the validated state of all of them. Most importantly, it includes the procedural controls and SOPs that instruct individuals how to operate the system.
A: The HMI/SCADA system and the PLC function together. The PLC is the field controller that runs the process and collects the raw data. The HMI/SCADA system is the interface that graphically displays this data to the operator, controls user accounts and permissions, offers the screen for entering electronic signatures, and shows the audit trail for review. The HMI/SCADA system usually performs the "human-facing" part of compliance.

Pharmaceutical companies are subject to stringent FDA quality and safety guidelines. PLC automation provides a practical, efficient solution to compliance attainment and sustainability. By investing in the appropriate systems and best practices, companies can safeguard their products, reputation, and clients.